# Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)

> **NCT00986960** · PHASE2 · WITHDRAWN · sponsor: **University at Buffalo**

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** repository corticotropin injection
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00986960
- **Lead sponsor:** University at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficult to recruit due to protocol requirements - participant burden.
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986960, "Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00986960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*